Antonio Guglietta - Pharmaceutical and ...

Dr. Antonio Guglietta, MD

Claim this profile

Investigator Site 0810015

Studies Thrombocytopenia
Studies Immune Thrombocytopenic Purpura
13 reported clinical trials
9 drugs studied

Area of expertise

1Thrombocytopenia
Antonio Guglietta, MD has run 4 trials for Thrombocytopenia. Some of their research focus areas include:
corticosteroids
danazol
vinca alkaloids
2Immune Thrombocytopenic Purpura
Antonio Guglietta, MD has run 4 trials for Immune Thrombocytopenic Purpura. Some of their research focus areas include:
corticosteroids
danazol
vinca alkaloids

Affiliated Hospitals

Image of trial facility.
Investigator Site 10 - US0010088
Image of trial facility.
Investigator Site 44 - US0010106

Clinical Trials Antonio Guglietta, MD is currently running

More about Antonio Guglietta, MD

Clinical Trial Related3 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Antonio Guglietta, MD has experience with
  • Efgartigimod PH20 SC
  • Efgartigimod
  • Placebo
  • Efgartigimod PH20 SC
  • Prednisone
  • ARGX-117

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Antonio Guglietta, MD specialize in?
Antonio Guglietta, MD focuses on Thrombocytopenia and Immune Thrombocytopenic Purpura. In particular, much of their work with Thrombocytopenia has involved corticosteroids patients, or patients who are danazol.
Is Antonio Guglietta, MD currently recruiting for clinical trials?
Yes, Antonio Guglietta, MD is currently recruiting for 1 clinical trial in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Antonio Guglietta, MD has studied deeply?
Yes, Antonio Guglietta, MD has studied treatments such as efgartigimod PH20 SC, Efgartigimod, Placebo.
What is the best way to schedule an appointment with Antonio Guglietta, MD?
Apply for one of the trials that Antonio Guglietta, MD is conducting.
What is the office address of Antonio Guglietta, MD?
The office of Antonio Guglietta, MD is located at: Investigator Site 0010045, Washington, District of Columbia 20007 United States. This is the address for their practice at the Investigator Site 0010045.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security